Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development (Q37853691)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 March 2011

Language	Label	Description	Also known as
English	Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development	scientific article published on 15 March 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Eric Leblanc

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Fabrice Narducci

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Isabelle Farre

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jean-Philippe Peyrat

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sophie Taieb

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Claude Adenis

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Philippe Vennin

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

15 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

472-476

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Hereditary ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Reproductive issues for women with BRCA mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Increased cardiovascular mortality after early bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Precursors to pelvic serous carcinoma and their clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

The genesis and evolution of high-grade serous ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

The origin of ovarian carcinomas: a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Meta-analysis of BRCA1 and BRCA2 penetrance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.012

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.02.012

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37853691&oldid=2216966798"